ATC code D01: Difference between revisions
Appearance
Content deleted Content added
m +pl: |
m spacing |
||
(30 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{ATC codes lead|D|01|Antifungals for dermatological use|vet=add}} |
|||
A section of the [[Anatomical Therapeutic Chemical Classification System]]. |
|||
⚫ | |||
[[ATC code D|D Dermatologicals]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
:D01AA01 [[Nystatin]] |
:D01AA01 [[Nystatin]] |
||
:D01AA02 [[Natamycin]] |
:D01AA02 [[Natamycin]] |
||
Line 13: | Line 12: | ||
:D01AA08 [[Griseofulvin]] |
:D01AA08 [[Griseofulvin]] |
||
:D01AA20 Combinations |
:D01AA20 Combinations |
||
===D01AC [[Imidazole]] and [[triazole]] derivatives=== |
==={{anchor|D01AC}}D01AC [[Imidazole]] and [[triazole]] derivatives=== |
||
:D01AC01 [[Clotrimazole]] |
:D01AC01 [[Clotrimazole]] |
||
:D01AC02 [[Miconazole]] |
:D01AC02 [[Miconazole]] |
||
Line 30: | Line 30: | ||
:D01AC15 [[Fluconazole]] |
:D01AC15 [[Fluconazole]] |
||
:D01AC16 [[Flutrimazole]] |
:D01AC16 [[Flutrimazole]] |
||
:D01AC17 [[Eberconazole]] |
|||
:D01AC20 Combinations |
|||
:D01AC18 [[Luliconazole]] |
|||
:D01AC19 [[Efinaconazole]] |
|||
:D01AC20 Imidazoles/triazoles in combination with [[corticosteroid]]s |
|||
:D01AC21 [[Neticonazole]] |
|||
:D01AC22 [[Lanoconazole]] |
|||
:D01AC52 Miconazole, combinations |
:D01AC52 Miconazole, combinations |
||
:D01AC60 Bifonazole, combinations |
:D01AC60 Bifonazole, combinations |
||
:QD01AC90 [[Enilconazole]] |
|||
⚫ | |||
⚫ | |||
:D01AE01 [[Bromochlorosalicylanilide]] |
:D01AE01 [[Bromochlorosalicylanilide]] |
||
:D01AE02 [[Methylrosaniline]] |
:D01AE02 [[Methylrosaniline]] |
||
Line 46: | Line 53: | ||
:D01AE11 [[Haloprogin]] |
:D01AE11 [[Haloprogin]] |
||
:D01AE12 [[Salicylic acid]] |
:D01AE12 [[Salicylic acid]] |
||
:D01AE13 [[Selenium sulfide]] |
:D01AE13 [[Selenium disulfide|Selenium sulfide]] |
||
:D01AE14 [[Ciclopirox]] |
:D01AE14 [[Ciclopirox]] |
||
:D01AE15 [[Terbinafine]] |
:D01AE15 [[Terbinafine]] |
||
Line 57: | Line 64: | ||
:D01AE22 [[Naftifine]] |
:D01AE22 [[Naftifine]] |
||
:D01AE23 [[Butenafine]] |
:D01AE23 [[Butenafine]] |
||
:D01AE24 [[Tavaborole]] |
|||
⚫ | |||
:D01AE25 [[Liranaftate]] |
|||
⚫ | |||
:D01AE54 [[Undecylenic acid]], combinations |
|||
:QD01AE91 [[Bronopol]] |
|||
:QD01AE92 [[Bensuldazic acid]] |
|||
⚫ | |||
⚫ | |||
:D01BA01 [[Griseofulvin]] |
:D01BA01 [[Griseofulvin]] |
||
:D01BA02 [[Terbinafine]] |
:D01BA02 [[Terbinafine]] |
||
:D01BA03 [[Fosravuconazole]] |
|||
==References== |
|||
{{Reflist}} |
|||
{{Antifungals}} |
|||
[[Category:ATC codes]] |
|||
[[ |
[[Category:ATC codes|D01]] |
||
[[Category:Antifungals for dermatologic use| ]] |
Latest revision as of 07:05, 31 December 2022
ATC code D: Dermatologicals |
---|
|
ATCvet only |
Other ATC codes |
ATC code D01 Antifungals for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D01 is part of the anatomical group D Dermatologicals.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
D01A Antifungals for topical use
[edit]D01AA Antibiotics
[edit]- D01AA01 Nystatin
- D01AA02 Natamycin
- D01AA03 Hachimycin
- D01AA04 Pecilocin
- D01AA06 Mepartricin
- D01AA07 Pyrrolnitrin
- D01AA08 Griseofulvin
- D01AA20 Combinations
- D01AC01 Clotrimazole
- D01AC02 Miconazole
- D01AC03 Econazole
- D01AC04 Clomidazole
- D01AC05 Isoconazole
- D01AC06 Tiabendazole
- D01AC07 Tioconazole
- D01AC08 Ketoconazole
- D01AC09 Sulconazole
- D01AC10 Bifonazole
- D01AC11 Oxiconazole
- D01AC12 Fenticonazole
- D01AC13 Omoconazole
- D01AC14 Sertaconazole
- D01AC15 Fluconazole
- D01AC16 Flutrimazole
- D01AC17 Eberconazole
- D01AC18 Luliconazole
- D01AC19 Efinaconazole
- D01AC20 Imidazoles/triazoles in combination with corticosteroids
- D01AC21 Neticonazole
- D01AC22 Lanoconazole
- D01AC52 Miconazole, combinations
- D01AC60 Bifonazole, combinations
- QD01AC90 Enilconazole
D01AE Other antifungals for topical use
[edit]- D01AE01 Bromochlorosalicylanilide
- D01AE02 Methylrosaniline
- D01AE03 Tribromometacresol
- D01AE04 Undecylenic acid
- D01AE05 Polynoxylin
- D01AE06 2-(4-chlorphenoxy)-ethanol
- D01AE07 Chlorphenesin
- D01AE08 Ticlatone
- D01AE09 Sulbentine
- D01AE10 Ethyl hydroxybenzoate
- D01AE11 Haloprogin
- D01AE12 Salicylic acid
- D01AE13 Selenium sulfide
- D01AE14 Ciclopirox
- D01AE15 Terbinafine
- D01AE16 Amorolfine
- D01AE17 Dimazole
- D01AE18 Tolnaftate
- D01AE19 Tolciclate
- D01AE20 Combinations
- D01AE21 Flucytosine
- D01AE22 Naftifine
- D01AE23 Butenafine
- D01AE24 Tavaborole
- D01AE25 Liranaftate
- D01AE54 Undecylenic acid, combinations
- QD01AE91 Bronopol
- QD01AE92 Bensuldazic acid
D01B Antifungals for systemic use
[edit]D01BA Antifungals for systemic use
[edit]- D01BA01 Griseofulvin
- D01BA02 Terbinafine
- D01BA03 Fosravuconazole
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code D01". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QD01". WHO Collaborating Centre for Drug Statistics Methodology.